Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» XON's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

XON Guru Trades in Q1 2016

George Soros 57,100 sh (New)
Chase Coleman 2,093,199 sh (+24.97%)
First Eagle Investment 1,187,389 sh (unchged)
Joel Greenblatt 23,282 sh (-59.45%)
» More
Q2 2016

XON Guru Trades in Q2 2016

John Burbank 19,981 sh (New)
Murray Stahl 17,439 sh (New)
Joel Greenblatt 28,320 sh (+21.64%)
Chase Coleman Sold Out
George Soros Sold Out
First Eagle Investment 1,102,004 sh (-7.19%)
» More
Q3 2016

XON Guru Trades in Q3 2016

First Eagle Investment 1,102,004 sh (unchged)
Joel Greenblatt Sold Out
John Burbank Sold Out
Murray Stahl 14,592 sh (-16.33%)
» More
Q4 2016

XON Guru Trades in Q4 2016

Murray Stahl 16,416 sh (+12.50%)
First Eagle Investment 1,102,004 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with XON

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 541711    SIC: 8731
Compare:NAS:KITE, OTCPK:BTGGF, NAS:BLUE, NAS:CLVS, NAS:CBPO, NAS:JUNO, NAS:SAGE, NAS:RARE, NAS:ICPT, NAS:GLPG, NAS:AGIO, NAS:LGND, OTCPK:ABCZF, NAS:ALNY, NAS:NKTR, NAS:ONCE, NAS:ARRY, NAS:PRTA, NAS:PTLA, NAS:DBVT » details
Traded in other countries:I5X.Germany,
Intrexon Corp is a synthetic biology company that designs, builds and regulates gene programs using its proprietary and complementary technologies.

Intrexon Corp was founded in 1998. The Company designs, builds and regulates gene programs and cellular systems to enable the development of new and improved products and processes across a variety of market sectors, including Health, Food, Energy and Environment.The Company operates in one segment. It uses synthetic biology for the creation of distinct products developed in collaboration with partners. All of the Company's revenues are derived in the United States of America and all of its assets are located in the United States of America. The Company is subject to various federal, state and local environmental laws, rules and regulations, including those relating to the discharge of materials into the air, water and ground, the generation, storage, handling, use, transportation and disposal of hazardous materials and the health and safety of employees with respect to laboratory activities required for the development of products and technologies.

Top Ranked Articles about Intrexon Corp

Weekly CEO Buys Highlight Insiders invest in Paycom, Intrexon, Akamai, Inovalon, Covanta
According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below: Read more...
CEO of Intrexon Invests in Company Insider purchases 34,606 shares
Randal Kirk (Insider Trades), CEO and 10% owner of Intrexon Corp. (XON), purchased 34,606 shares on Dec. 13. The price per share was $28.90 for a total transaction of $1,000,113. Read more...

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $186.4
EPS (TTM) $ -1.50
Beta2.28
Short Percentage of Float32.82%
52-Week Range $20.39 - 39.85
Shares Outstanding (Mil)118.58
» More Articles for XON

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight Dec 19 2016 
CEO of Intrexon Invests in Company Dec 15 2016 
The Emperor Has No Clothes Aug 17 2016 
CEO and Part Owner of JMP Group Invests in Company Jan 20 2016 
Intrexon Corp is expanding his business Jun 25 2015 
Bill Miller Identifies What Could Be The Stock of The Decade Feb 10 2015 
5-Year Lows: American Eagle Outfitters, Intrexon Corp, Mack-Cali Realty Corp, and Weight Watchers In Apr 20 2014 
Daniel Loeb Comments on Intrexon Corporation Jan 22 2014 
Daniel Loeb Lags S&P But Top New Stocks Advance Jan 07 2014 
David Einhorn’s New Stocks – TPX, XON, NVR Nov 14 2013 

More From Other Websites
Fibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for... Feb 23 2017
Intrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on March 1st Feb 22 2017
ZIOPHARM Reports Fourth-Quarter 2016 Financial Results and Provides Update on Recent Activities Feb 16 2017
GMOs and engineered biology Feb 16 2017
Lt. Gen. (Ret.) Thomas P. Bostick, Head of Intrexon's Environment Sector, Elected to National... Feb 13 2017
Why Bill Miller Likes Apple, Intrexon, Bets on Fiat Chrysler and Considers OneMain Holdings the... Feb 06 2017
Bill Miller is bullish about this Maryland biotech that makes non-browning apples Feb 02 2017
GENVEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC... Feb 02 2017
Bill Miller: Apple's cheap but this 'arctic apple' stock ... Feb 02 2017
ZIOPHARM Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells... Jan 31 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of... Jan 26 2017
Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease Jan 26 2017
INTREXON CORP Financials Jan 25 2017
Intrexon To Buy GenVec In Stock Deal For $7/Shr Jan 25 2017
INTREXON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 24 2017
Intrexon to acquire fellow Md. biotech Jan 24 2017
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform Jan 24 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)